Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Financing Cash Flow

$4.47M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Financing Cash Flow

Latest reported$4.47Mperiod endingJun 30, 2026

Latest reported$4.47Mperiod endingJun 30, 2026

LCTX Quarterly Cash from Financing (-$200.00K → $4.47M)

Quarterly financing cash flow

High-resolution chart · PNG

LCTX financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Financing Cash Flow — Quarterly (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	682,872
Mar 31, 2001	16,500
Dec 31, 2000	156,189
Sep 30, 2000	759,775
Jun 30, 2000	0
Mar 31, 2000	0
Dec 31, 1999	20,412
Sep 30, 1999	0
Jun 30, 1999	100,000
Mar 31, 1999	7,300,000
Sep 30, 1998	400,000
Jun 30, 1998	0
Mar 31, 1998	100,000
Dec 31, 1997	200,000
Sep 30, 1997	600,000
Jun 30, 1997	0
Mar 31, 1997	6,200,000
Dec 31, 1996	300,000
Sep 30, 1996	200,000
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	-100,000
Dec 31, 1994	-100,000
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	3,900,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	-100,000
Jun 30, 1992	-200,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.